Nothing endures but change. Heraclitus In the two months since I started receiving the clinical trial drug which still has no name, I have mentioned a few times that the medical team is trying to walk the line between helping and harming. Tomorrow, as we begin cycle 4 of the chemo protocol, there will once again be an adjustment that is aimed at keeping the treatment on the "helping" side of that line. The clinical trial drug will continue as is. Thus far it has resulted in over a 90% drop in the proteins that are markers of myeloma! One of the other established drugs, a steroid, will be eliminated completely because of its effects on our day to day life. The third drug will be dosed differently, in the hope of reducing some of the negative effects it has on peripheral nerves. One enters a clinical trial hoping for a steady path to healing but as it turns out, that path is characterized by enduring change and adjustment. I am #thankful God provides brilli...
Brian’s diagnosis of Multiple Myeloma was in May 2018. The initial treatment was a stem cell transplant. After 30 months there was a relapse, followed by chemo, another relapse, new chemo and yet another relapse. In January 2024, the 4th treatment began. Brian currently gets weekly injections of an immunotherapy drug. Sometimes we keep the faith and sometimes we need family and friends around us to keep the faith for us. This blog is about enabling us all to be kept in the faith.